RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

SMILES:

CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6C…

InChI Key:

FKRSSPOQAMALKA-CUPIEXAXSA-N

DrugBank ClinicalTrials.gov PubMed

Clinical Development by Virus2

HCV

Target: NS5A phosphoprotein

FDA approved

Preclinical

Phase 2positive

Phase 3positive

Approved

FDAJapan

Approval ref: AntiviralDbApproval ref (kegg.jp) Approval ref (pmda.go.jp) DB09102

Severe acute respiratory syndrome-related coronavirus

SARS-CoV-2

Target: Viral NS5A

Approved (other)

Preclinical

Phase 2

Phase 3

Approved

Japan

Approval ref (kegg.jp) Approval ref (pmda.go.jp) PMID:33071519